Aviso Financial Inc. Boosts Stock Position in CVS Health Corporation $CVS

Aviso Financial Inc. increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 8.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,073 shares of the pharmacy operator’s stock after buying an additional 1,263 shares during the period. Aviso Financial Inc.’s holdings in CVS Health were worth $1,109,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Avion Wealth increased its position in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 189 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in shares of CVS Health during the 2nd quarter worth $30,000. Bell Investment Advisors Inc increased its holdings in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC lifted its holdings in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC boosted its position in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CVS has been the topic of a number of recent analyst reports. Sanford C. Bernstein increased their price target on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Piper Sandler upped their price target on shares of CVS Health from $81.00 to $99.00 in a report on Friday, October 31st. Robert W. Baird raised CVS Health from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Barclays upped their target price on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $89.41.

CVS Health Stock Performance

Shares of CVS stock opened at $78.48 on Wednesday. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock has a fifty day moving average of $78.31 and a 200 day moving average of $70.46. The firm has a market capitalization of $99.63 billion, a price-to-earnings ratio of 206.54, a PEG ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the business earned $1.09 EPS. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.